110 related articles for article (PubMed ID: 6092190)
1. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
2. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
Tantry BV; Jain AK; Gupta S; Gupta JP
J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
Dusheiko GM; Kew MC; Rabson AR
Br J Cancer; 1979 Sep; 40(3):397-402. PubMed ID: 228691
[TBL] [Abstract][Full Text] [Related]
5. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
6. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
[TBL] [Abstract][Full Text] [Related]
7. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Fujii T; Horie Y; Ikuta Y; Nishimuki E; Murawaki Y; Suou T; Kawasaki H
Clin Chim Acta; 1995 Apr; 236(1):71-9. PubMed ID: 7545092
[TBL] [Abstract][Full Text] [Related]
9. Repeated micro-monocyte adherence inhibition assay: a new technique of leukocyte adherence inhibition to detect tumor immunity in patients with hepatoma.
Kumagai N; Morizane T; Inagaki Y; Nakamura T; Tsuchimoto K; Watanabe T; Tsuchiya M
Gan; 1984 Nov; 75(11):1017-24. PubMed ID: 6097491
[TBL] [Abstract][Full Text] [Related]
10. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients.
Lee CS; Chang KJ; Chen DS; Lin TY
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850
[TBL] [Abstract][Full Text] [Related]
11. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
12. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
13. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
14. Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity.
Prabha B; Kumary ; Vasudevan DM
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):891-7. PubMed ID: 6540190
[TBL] [Abstract][Full Text] [Related]
15. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
16. Purification of soluble hepatocellular carcinoma extracts.
Lee CS; Chuang CY; Lin FY; Lin TY
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):81-5. PubMed ID: 232674
[TBL] [Abstract][Full Text] [Related]
17. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
O'Connor R; MacFarlane JK; Murray D; Thomson DM
Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
[TBL] [Abstract][Full Text] [Related]
18. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
19. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
20. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]